Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.
Wadim KoslowMartin Joachim KühnSebastian BinderMargrit KlitzDaniel AbeleAchim BasermannMichael Meyer-HermannPublished in: PLoS Comput. Biol. (2022)
Keyphrases
- drug discovery
- risk management
- probabilistic relaxation
- risk measures
- public health
- structure extraction
- iterative algorithms
- risk factors
- data mining
- risk analysis
- severe acute respiratory syndrome
- minimum risk
- infectious disease
- high risk
- risk assessment
- decision makers
- decision making
- early warning
- semidefinite
- risk averse
- graphical models
- bayesian networks
- feature selection
- learning algorithm